Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines.

@article{Caracciolo2015LiposomeproteinCI,
  title={Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines.},
  author={Giulio Caracciolo},
  journal={Nanomedicine : nanotechnology, biology, and medicine},
  year={2015},
  volume={11 3},
  pages={543-57}
}
Active targeting that exploits the (over)expression of surface receptors in target cells by ligand incorporation is a central concept in nanomedicine research. Despite unprecedented efforts, no targeted liposome-based therapeutics is commercially available for clinical practice. What is inhibiting the efficient translation of targeted liposome technology… CONTINUE READING